Literature DB >> 21867751

(1)H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease.

Kim A Verwaest1, Trung N Vu, Kris Laukens, Laura E Clemens, Huu P Nguyen, Bjorn Van Gasse, José C Martins, Annemie Van Der Linden, Roger Dommisse.   

Abstract

Huntington disease (HD) is a hereditary brain disease. Although the causative gene has been found, the exact mechanisms of the pathogenesis are still unknown. Recent investigations point to metabolic and energetic dysfunctions in HD neurons. Both univariate and multivariate analyses were used to compare proton nuclear magnetic resonance spectra of serum and cerebrospinal fluid (CSF) taken from presymptomatic HD transgenic rats and their wild-type littermates. N-acetylaspartate (NAA), was found to be significantly decreased in the serum of HD rats compared to wild-type littermates. Moreover, in the serum their levels of glutamine, succinic acid, glucose and lactate are significantly increased as well. An increased concentration of lactate and glucose is also found in CSF. There is a 1:1 stoichiometry coupling glucose utilization and glutamate cycling. The observed increase in the glutamine concentration, which indicates a shutdown in the neuronal-glial glutamate-glutamine cycling, results therefore in an increased glucose concentration. The elevated succinic acid concentration might be due to an inhibition of succinate dehydrogenase, an enzyme linked to the mitochondrial respiratory chain and TCA cycle. Moreover, reduced levels of NAA may reflect an impairment of mitochondrial energy production. In addition, the observed difference in lactate supports a deficiency of oxidative energy metabolism in rats transgenic for HD as well. The observed metabolic alterations seem to be more profound in serum than in CSF in presymptomatic rats. All findings suggest that even in presymptomatic rats, a defect in energy metabolism is already apparent. These results support the hypothesis of mitochondrial energy dysfunction in HD. 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21867751     DOI: 10.1016/j.bbadis.2011.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  18 in total

1.  Metabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkey.

Authors:  Raghavendra Rao; Kathleen Ennis; Gulin Oz; Gabriele R Lubach; Michael K Georgieff; Christopher L Coe
Journal:  Neurochem Res       Date:  2012-12-28       Impact factor: 3.996

Review 2.  Role of cerebral cortex in the neuropathology of Huntington's disease.

Authors:  Ana M Estrada-Sánchez; George V Rebec
Journal:  Front Neural Circuits       Date:  2013-02-18       Impact factor: 3.492

3.  An integrated workflow for robust alignment and simplified quantitative analysis of NMR spectrometry data.

Authors:  Trung N Vu; Dirk Valkenborg; Koen Smets; Kim A Verwaest; Roger Dommisse; Filip Lemière; Alain Verschoren; Bart Goethals; Kris Laukens
Journal:  BMC Bioinformatics       Date:  2011-10-20       Impact factor: 3.169

4.  Metabolic disruption identified in the Huntington's disease transgenic sheep model.

Authors:  Renee R Handley; Suzanne J Reid; Stefano Patassini; Skye R Rudiger; Vladimir Obolonkin; Clive J McLaughlan; Jessie C Jacobsen; James F Gusella; Marcy E MacDonald; Henry J Waldvogel; C Simon Bawden; Richard L M Faull; Russell G Snell
Journal:  Sci Rep       Date:  2016-02-11       Impact factor: 4.379

5.  1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.

Authors:  Jin Pyeong Jeon; Taeho Yun; Xing Jin; Won-Sang Cho; Young-Je Son; Jae Seung Bang; Hyun-Seung Kang; Chang Wan Oh; Jeong Eun Kim; Sunghyouk Park
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

Review 6.  Towards an Understanding of Energy Impairment in Huntington's Disease Brain.

Authors:  Janet M Dubinsky
Journal:  J Huntingtons Dis       Date:  2017

7.  Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers.

Authors:  Debra J Skene; Benita Middleton; Cara K Fraser; Jeroen L A Pennings; Timothy R Kuchel; Skye R Rudiger; C Simon Bawden; A Jennifer Morton
Journal:  Sci Rep       Date:  2017-02-22       Impact factor: 4.379

8.  Metabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France).

Authors:  Nathalie Bonvallot; Marie Tremblay-Franco; Cécile Chevrier; Cécile Canlet; Charline Warembourg; Jean-Pierre Cravedi; Sylvaine Cordier
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

9.  Pre-symptomatic activation of antioxidant responses and alterations in glucose and pyruvate metabolism in Niemann-Pick Type C1-deficient murine brain.

Authors:  Barry E Kennedy; Veronique G LeBlanc; Tiffany M Mailman; Debra Fice; Ian Burton; Tobias K Karakach; Barbara Karten
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  NMR based metabonomics study on celiac disease in the blood serum.

Authors:  Fariba Fathi; Fatemeh Ektefa; Afsaneh Arefi Oskouie; Kamran Rostami; Mostafa Rezaei-Tavirani; Amir Houshang Mohammad Alizadeh; Mohsen Tafazzoli; Mohammad Rostami Nejad
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.